The government has given ₹10,000 crore to the biotechnology sector in the 2026–27 Budget.As a result, India can become a significant global hub for manufacturing medicines and biotech products.
Experts said this money will help improve research, build better labs, and train students. They also stated that universities, companies, and the government need to collaborate to support the growth of the biotech sector.
The goal is to increase the production of biologics and biosimilars through a new program called Biopharma Shakti. Experts said this will create many new opportunities for students who want to build a career in biotechnology.
The timing is right, and biotechnology is a safe and promising career, said Meenakshi Sinha, director at Cipla. She explained that healthcare demand is always increasing. With strong government support and investment, there are many job opportunities in both the Indian and global markets.
She was speaking at a webinar organised jointly by Vellore Institute of Technology, Chennai, and The Hindu as part of a new series titled “Biotechnology: Role in Industry 5.0 Sustainable Future Pathways”.
The series projects aim to show how biotechnology is changing and improving areas like healthcare, agriculture, environmental solutions, and research-based innovation.
S. Shridevi from Vellore Institute of Technology, Chennai, said that new technologies like AI, deep learning, and machine learning are helping scientists discover new medicines faster.
She said, healthcare is changing from treating illness after it happens to preventing it early.
Treatments are now more personal, based on a person’s genes, lifestyle, and background.
She said biotechnology education is evolving rapidly to match the changes in healthcare. It is now combining subjects like genomics, bioinformatics, data science, and clinical practice. This helps students and professionals understand how to design treatments based on a person’s genes and health profile.
The goal is to prepare experts who can work in personalised medicine, where care is tailored to each individual. This new approach will make healthcare more effective and precise.
Mansi Kadam is a market research writer with over 3 years of experience analyzing trends in the healthcare industry. At Towards Healthcare, she covers innovations in medical sector, sustainability initiatives, and the evolving regulatory landscape.
